Navigation Links
Treatment for Syndrome X

Syndrome X is a disorder that many people are at risk for developing by the time they reach middle age. Syndrome X is why many people feel lousy and tired all the time, and it can put them at risk// for health problems such as heart disease, diabetes, Alzheimer's, cancer and other age-related diseases.

Syndrome X refers specifically to the health problems that include insulin resistance, abnormal blood fats, overweight and high blood pressure. New research shows an effective solution for syndrome X is the combination of exercise and weight loss.

Researchers conducted a study to determine if a six-month intervention could have an effect on coronary heart disease risk factors associated with syndrome X.

The study included 53 men and women who were part of a larger clinical trial. The participants suffered from insulin resistance, abnormal blood fats and high blood pressure. They were randomly assigned to the exercise only group, exercise and structured weight-loss program group, or the group that was on the waiting list for treatment. Before and after treatment, the participants underwent a variety of tests including glucose tolerance, lipid levels and blood pressure measurements.

Researchers found the response to glucose in the body was significantly reduced in both the exercise only and exercise/weight-loss groups. They say participants who lost the most amount of weight showed the most improvements in abnormal insulin responses. Researchers also report the diastolic blood pressure level was significantly reduced in the exercise/weight-loss group, but not in the exercise only group. The lipid or fat profile was not significantly improved in either intervention group.

Researchers thus conclude, the combination of exercise and weight loss is an effective treatment for hyperinsulinemia (failure of blood sugar control system) and lowering diastolic blood pressure in patients with syndrome X.


'"/>




Page: 1

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/22/2017)... NEV. (PRWEB) , ... August 22, 2017 , ... ... Academy of Anti-Aging Medicine recently spoke at a popular international aesthetics conference for ... has had on restoring his patients’ health and his growing practice. , ...
(Date:8/22/2017)... ... 22, 2017 , ... Nurses at Apple Rehab Watch Hill , a ... training and certification in Closed Pulse Irrigation™ (CPI) for wound care. This ... the Centers for Medicare and Medicaid Services, to have a CPI machine that will ...
(Date:8/22/2017)... ... 22, 2017 , ... “Without Love’s Beauty and Pleasures Life ... struggles faced while hoping for a better life. “Without Love’s Beauty and Pleasures ... who spent 13 years working with deprived/neglected adolescents and almost 20 years working ...
(Date:8/22/2017)... Park, KS (PRWEB) , ... August 22, 2017 , ... ... of products to fight Fatigue . , As the stress of modern life ... keep up the pace. Constant use of artificial stimulants can trap people in vicious ...
(Date:8/21/2017)... (PRWEB) , ... August 22, 2017 , ... ... but not without risk to health and safety. By learning and implementing best ... eliminated. , In this webinar, attendees will gain a better understanding of ...
Breaking Medicine News(10 mins):
(Date:8/2/2017)... 2017 Fenita J. Caldwell ... Pinnacle Lifetime Professional in the Field of Healthcare. ... Turing Pharmaceuticals, AG. Her skills and areas of ... ... of experience as a highly successful sales specialist ...
(Date:8/1/2017)...   CerSci Therapeutics , a non-opioid drug development ... has received notice from the National Institute on Drug ... that it has been awarded a Direct-to-Phase II Small ... 2017 with an additional $1,000,000 to follow in 2018. ... of their lead non-opioid drug candidate CT-044 to the ...
(Date:7/28/2017)... 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), ... ended June 30, 2017, and updated its financial outlook ... For the fiscal third quarter, Hill-Rom reported earnings ... diluted share in the prior-year period. These results reflect ... diluted share primarily related to the non-cash write-down of ...
Breaking Medicine Technology: